Drug Trial Radar · NCT00732849
The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery
Last checked: Nov 20, 2026Latest source record: Aug 12, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
600
Actual
Start
Jun 2002
Primary completion
Sep 2002
Study completion Nov 2007
Sponsor
- Lead sponsor
- Jagiellonian UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 12, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study was designed to test the hypothesis that immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patients following elective upper GI surgery
Conditions
- Gastrointestinal Surgery
Interventions
Reconvan, Dipeptiven, OmegavenDrug
Reconvan (1ml=1 kcal), 30 kcal/kg b.w. Omegaven 1 ml/ kg b.w. Dipeptiven 1 ml/ kg b.w.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patientsTime frame: Immunonutrition
Locations
1 site in 1 country. Site status is shown where the registry gives one.
1st Department of SUegy
Krakow, _30978, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.